Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known whether fluorouracil and leucovorin plus
irinotecan is more effective than fluorouracil and leucovorin alone for colorectal cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of fluorouracil and
leucovorin with or without irinotecan in treating patients who have metastatic colorectal
cancer.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC